India launches world’s 1st clinical trial to test Ayurveda with TB treatment

(File Photo/IANS)

New Delhi, (IANS) On the occasion of World Tuberculosis Day, India announced the world’s first clinical study to scientifically evaluate Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment (ATT), the government said on Tuesday.

The collaborative clinical study between the Department of Biotechnology and the Ministry of Ayush will enrol 1,250 newly diagnosed tuberculosis patients across eight institutions to evaluate Ayurveda as an adjunct to standard treatment, focusing on body weight, nutritional outcomes, disease progression, quality of life, safety, and tolerability.

Union MoS for Science & Technology Jitendra Singh said the study reflects the spirit of “whole-of-science,” approach by integrating biotechnology and Ayurveda; “whole-of-government” approach through collaboration between ministries.

DG, CCRAS, Prof. Vaidya Rabinarayan Acharya said the initiative has progressed through consultations, protocol finalisation, and approvals.

Director, BRIC-NII, Dr. Debasisa Mohanty said the study will examine tuberculosis-associated cachexia as an immune-metabolic condition, using advanced tools such as DEXA, MRI, immune profiling, metabolomics, and single-cell RNA sequencing to understand changes in body composition, immune function, and energy metabolism.

It is aimed to assess how integrative interventions influence recovery and long-term outcomes, the statement from the Ministry of Science & Technology said.

Minister Jitendra Singh said India, which accounts for nearly 25 per cent of the global TB burden, saw a 21 per cent drop in a decade in tuberculosis incidence to about 187 cases per 1,00,000 population in 2024.

“The decline in TB incidence is an outcome of India’s dedicated and innovative efforts. Through a collective spirit, we will keep working towards a TB-free India,” he quoted Prime Minister Narendra Modi.

India has adopted an ambitious and accelerated pathway towards TB elimination, strengthening early diagnosis, universal drug susceptibility testing, digital adherence technologies, and patient-centric care under the National TB Elimination Programme, the minister said.

He pointed out the reciprocal relationship between TB and conditions such as diabetes, where each can aggravate the other, making integrated approaches essential for effective disease management.He also referred to the RePORT India programme, one of the largest TB research consortia, with over 4,500 enrolled TB patients and over 5,000 household contacts, generating evidence relevant for global policy frameworks, including WHO guidelines on nutrition and tuberculosis. India launches world’s 1st clinical trial to test Ayurveda with TB treatment | MorungExpress | morungexpress.com

Read More........→April 02, 2026

First Quantum Battery Prototype Marks Big Step for Technology Expected to Change the World

The prototype quantum battery – credit, CSIRO

Australian researchers have developed and tested the world’s first quantum battery.

Their prototype is far from anything that will be a perspective power source in an EV or storage facility, but the experiment revealed some important directions for future research.

A theoretical concept since 2013, the prototype was charged wirelessly with a laser, one of the special properties that quantum mechanics in battery technology promises if it can be properly understood and harnessed.

Lead researcher Dr. James Quach of CSIRO, Australia’s national science agency which led the study on the device, said it’s the first quantum battery ever made that performs a full charge-discharge cycle.

Dr. Quach explained that in society today, the larger the battery, the longer the charge time.

“That’s why your mobile phone takes about 30 minutes to charge and your electric car takes overnight to charge,” he said, adding that in contrast, “quantum batteries have this really peculiar property where the larger they are, the less time they take to charge.”

Less time really is an almost worthless descriptor in this case, because the prototype created by CSIRO was fully charged within a few quadrillionths of a second.

The problem is that the discharge rate was a few nanoseconds, which despite being 6 orders of magnitude longer, could be of no use to anyone now. Quach provided some interesting relative comparisons to help mere mortals conceptualize why this could be a world-changing innovation if improved.

If it takes 30 minutes to fully charge a mobile phone, and it too had a discharge rate equal to 6 orders of magnitude, that means it wouldn’t need to be recharged even after a decade of use.

“What we need to do next is… to increase the storage time,” Quach said, touching on this point. “You want your battery to hold charge longer than a few nanoseconds if you want to be able to talk to someone on a mobile phone.”

Additionally, the prototype doesn’t hold enough voltage to power anything substantial.

While this might all sound rather pointless, another, non-involved expert in the development of quantum batteries, University of Queensland Professor Andrew White, told the Guardian that the experiment was a huge success in getting the technology off the drawing board and into the real world for the first time.People would be far more likely to adopt EVs if they could be fully-charged in few seconds, even if their range was severely reduced. First Quantum Battery Prototype Marks Big Step for Technology Expected to Change the World

Read More........→April 01, 2026